Protara Therapeutics Inc (TARA) stock is lower by -68.57% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives TARA stock a score of 28 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 0. TARA's rank also includes a long-term technical score of 1. The fundamental score for TARA is 82. In addition to the average rating from Wall Street analysts, TARA stock has a mean target price of $40.00. This means analysts expect the stock to rise 489.97% over the next 12 months.
TARA has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on TARA!
Protara Therapeutics Inc (TARA) stock is higher by 0.8% while the S&P 500 has risen 0.63% as of 11:17 AM on Tuesday, Oct 19. TARA has risen $0.05 from the previous closing price of $6.73 on volume of 47,746 shares. Over the past year the S&P 500 is up 31.74% while TARA is lower by -68.57%. TARA lost -$4.38 per share in the over the last 12 months.
Click Here to get the full Stock Report for Protara Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
